Skip to main content
main-content

Zeitschrift

Clinical Pharmacokinetics

Clinical Pharmacokinetics 7/2019

Ausgabe 7/2019

Inhaltsverzeichnis ( 18 Artikel )

04.04.2019 | Current Opinion | Ausgabe 7/2019 Open Access

Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude Ferran, Pierre-Louis Toutain

28.02.2019 | Review Article | Ausgabe 7/2019 Open Access

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Maddalena Centanni, Dirk Jan A. R. Moes, Iñaki F. Trocóniz, Joseph Ciccolini, J. G. Coen van Hasselt

13.02.2019 | Review Article | Ausgabe 7/2019 Open Access

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab

Kioa Lente Wijnsma, Rob ter Heine, Dirk Jan A. R. Moes, Saskia Langemeijer, Saskia E. M. Schols, Elena. B. Volokhina, Lambertus P. van den Heuvel, Jack F. M. Wetzels, Nicole C. A. J. van de Kar, Roger J. Brüggemann

07.11.2018 | Systematic Review | Ausgabe 7/2019

Interactions Between Antiepileptic and Antibiotic Drugs: A Systematic Review and Meta-Analysis with Dosing Implications

Carla Carnovale, Marco Pozzi, Faizan Mazhar, Giulia Mosini, Marta Gentili, Gabriëlla G. A. M. Peeters, Emilio Clementi, Sonia Radice

06.03.2019 | Original Research Article | Ausgabe 7/2019

Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children

Elizabeth J. Thompson, Huali Wu, Anil Maharaj, Andrea N. Edginton, Stephen J. Balevic, Marjan Cobbaert, Anthony P. Cunningham, Christoph P. Hornik, Michael Cohen-Wolkowiez

27.02.2019 | Original Research Article | Ausgabe 7/2019

The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group

Ryan J. Beechinor, Patrick A. Thompson, Michael F. Hwang, Ryan C. Vargo, Lisa R. Bomgaars, Jacqueline G. Gerhart, ZoAnn E. Dreyer, Daniel Gonzalez

24.01.2019 | Original Research article | Ausgabe 7/2019

Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John’s Wort

Jeffry Adiwidjaja, Alan V. Boddy, Andrew J. McLachlan

15.02.2019 | Original Research Article | Ausgabe 7/2019

Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults

Guo-Fu Li, Qing-Shan Zheng, Yichao Yu, Wei Zhong, Hong-Hao Zhou, Furong Qiu, Guangji Wang, Guo Yu, Hartmut Derendorf

11.03.2019 | Original Research Article | Ausgabe 7/2019 Open Access

Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with Asthma

Li Yan, Bing Wang, Yen Lin Chia, Lorin K. Roskos

03.06.2019 | Letter to the Editor | Ausgabe 7/2019

Comment on: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”

Patrick Nicolas

03.06.2019 | Letter to the Editor | Ausgabe 7/2019 Open Access

Authors’ Reply to Nicolas: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”

Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, Pierre-Louis Toutain

03.06.2019 | Letter to the Editor | Ausgabe 7/2019

Comment on: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”

Joël Coste, Xavier Bertagna, Mahmoud Zureik

03.06.2019 | Letter to the Editor | Ausgabe 7/2019 Open Access

Authors’ Reply to Coste et al.: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”

Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, Pierre-Louis Toutain

12.06.2019 | Letter to the Editor | Ausgabe 7/2019 Open Access

Comment on “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”

Alain Munafo, Axel Krebs-Brown, Sumedh Gaikwad, Bogumila Urgatz, Claire Castello-Bridoux

12.06.2019 | Letter to the Editor | Ausgabe 7/2019 Open Access

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”

Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, Pierre-Louis Toutain

12.06.2019 | Letter to the Editor | Ausgabe 7/2019

Comment on: Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?

Philippe Tréchot

12.06.2019 | Letter to the Editor | Ausgabe 7/2019

Author’s Reply to Trechot: “Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”

Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, Pierre-Louis Toutain

02.05.2019 | Letter to the Editor | Ausgabe 7/2019

Comment on “Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients”

Iris K. Minichmayr, Markus Zeitlinger

Aktuelle Ausgaben